News

Biologic Therapeutics Market to Hit $794.5 Billion by 2029
According to the latest study from BCC Research, "Biologic Therapeutic Drugs: Technologies and Global Markets" is projected ...
GSK signs US$12.5 billion licence deal with Hengrui as China rises in global pharmaceuticals
The deal would give GSK the rights to develop the drug for HRD-9821 and 11 preclinical programmes owned by Jiangsu Hengrui ...
KrASIA17h
Pfizer inks record China drug deal
Pfizer has licensed global rights to 3SBio’s cancer drug SSGJ-707 for USD 1.25 billion upfront, in what may be the largest single-drug deal in China’s biotech sector. It will pay an additional USD 150 ...